Nothing Special   »   [go: up one dir, main page]

WO2001070190A2 - Compositions cosmetiques - Google Patents

Compositions cosmetiques Download PDF

Info

Publication number
WO2001070190A2
WO2001070190A2 PCT/EP2001/002736 EP0102736W WO0170190A2 WO 2001070190 A2 WO2001070190 A2 WO 2001070190A2 EP 0102736 W EP0102736 W EP 0102736W WO 0170190 A2 WO0170190 A2 WO 0170190A2
Authority
WO
WIPO (PCT)
Prior art keywords
skin
composition
acid
titanium dioxide
precursor
Prior art date
Application number
PCT/EP2001/002736
Other languages
English (en)
Other versions
WO2001070190A3 (fr
Inventor
Govindarajan Raman
Pushker Sona
Ramesh Surianarayanan
Sushama Shripad Wagh
Original Assignee
Unilever Plc
Unilever Nv
Hindustan Lever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever Nv, Hindustan Lever Limited filed Critical Unilever Plc
Priority to AU2001256202A priority Critical patent/AU2001256202A1/en
Publication of WO2001070190A2 publication Critical patent/WO2001070190A2/fr
Publication of WO2001070190A3 publication Critical patent/WO2001070190A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Definitions

  • the present invention relates to cosmetic compositions for lightening skin colour.
  • the compositions of the invention are directed for topical application to human skin to provide lightening of skin colour .
  • Melanin is synthesised by melanocytes, a cell type present at dermis-epidermis junction, from an ammo acid tyrosine. Tyrosine is acted upon by an enzyme tyrosmase which is the key enzyme in melanogenesis .
  • tyrosmase is the key enzyme in melanogenesis .
  • inhibitors of tyrosmase such as hydroquinone and its derivatives, mercaptoammes, alpha hydroxy acids and others have been used in cosmetic compositions to regulate the skin pigmentation. However only some of these are reversible and non-toxic.
  • the conventional skin lightening compositions are based on sunscreens which maintain skin colour against ultra violet (u.v.) light and have been based on materials which absorb incident ultra violet light of the wavelength which produces the tanning of the skin.
  • Other approaches have been to use niac /niacmamide or other skin lightening agents which are believed to control dispersion of melanosomes or inhibit tyrosmase.
  • Sunscreens alone can not lighten the skin beyond the natural skin colour, and their action on the skin is only to reduce the ingress of incident u.v. into the skin, and are therefore effective only during the day.
  • Some of the compounds used as skin lightening agents are also known to be toxic.
  • GB 1533119 discloses the combination of niacinamide and a suitable mixture of UV absorbers which absorb in the UV range of 290 nm to 360 nm.
  • IN 169917 discloses the use of silicone compound to synergistically enhance the skin lightening benefit obtained from the combination of niacinamide and sunscreens.
  • Certain inorganic substances have also been proposed for use as sunscreens which physically block exposure of the skin to ultra-violet rays.
  • titanium dioxide having very small particle size. This grade of titanium dioxide designated as ultrafine T ⁇ 0 , affords a good degree of sun blocking potential without causing any skin lightening effect.
  • IN 172889 discloses use of titanium dioxide at levels from 3% along with octyl methoxy c namate to give protection from excessive exposure to ultra-violet rays over a large range of wavelengths in the UV-A and UV-B regions .
  • US 5,997,887 and US 5,997,890 disclose a topical composition
  • a topical composition comprising pigmentary grade particulate material such as titanium dioxide, with a particle size greater than lOOnm to about 300nm along with an active selected from inter alia vitamin B3 useful for imparting an essentially immediate visual improvement in skin appearance.
  • a synergistic composition comprising titanium dioxide with a particle size less than 100 nm enhances the anti-tanning benefit of the composition and skin lightening efficacy of niacinamide. It was found that for obtaining the synergy in skin lightening it is essential to use titanium dioxide with a particle size less than lOOnm.
  • the present invention relates to a cosmetic skin lightening composition
  • a cosmetic skin lightening composition comprising a skin lightening agent or a precursor thereof (preferably m an amount of from 0.1% to 10% by weight) and titanium dioxide with a particle size less than lOOnm (preferably in an amount of from 0.1 to 5% by weight) .
  • the invention provides the use of a composition according to the invention in a cosmetic method for lightening the colour of skin.
  • the invention provides a cosmetic method of treating skin which comprises applying to the skin a composition according to the invention.
  • a yet further aspect of the invention is the use of a composition according to the invention in the manufacture of a sunscreen.
  • Also provided by the invention is a method of reducing or preventing the tanning of skin which comprises applying to the skin a composition according to the invention .
  • composition of the invention comprises a skin lightening agent or a precursor thereof and titanium dioxide with a particle size less than 100 nm.
  • the composition further comprises from 0.1 to 10% by weight of at least one organic sunscreen.
  • the preferred skm lightening agent is niacinamide or a precursor thereof.
  • a preferred aspect of the present invention relates to a cosmetic skm lightening composition
  • a cosmetic skm lightening composition comprising 0.1% to 10% by weight of niacinamide or a precursor thereof and 0.1 to 5% by weight titanium dioxide with a particle size less than 100 nm.
  • a more preferred aspect of the invention is a cosmetic skm lightening composition
  • a cosmetic skm lightening composition comprising 0.1% to 10% by weight of niacinamide or a precursor thereof; 0.1 to 5% by weight titanium dioxide with particle size less than 100 nm; and 0.1 to 10 % by weight of at least one organic sunscreen.
  • composition of the invention is reversible and without any side effects.
  • the composition according to the invention would be active both during the day and the night unlike sunscreens, which can act only during the day.
  • niacinamide or a precursor thereof extracts of placenta, hydroqumone and derivatives (eg. arbutm) , kojic acid, dicarboxylic
  • the amino acids forming the polyamino acid sequence can be naturally occurring or synthetic, dextro or levo form, and the polyamino acid sequence can be straight chain or cyclised with a molecular weight of 200-20000. Any of the other known skin lightening agents such as those obtained from plants or fungi etc. may also be employed.
  • the organic sunscreens used in the composition according to the invention may, for example, be selected from 4-tertiary butyl-4 ' -methoxy dibenzoylmethane, octyl methoxy cinnamate, Benzophenone-3, Benzophenone-4 , Benzophenone-8 , diethanolamine methoxy cinnamate, ethyl dihydroxypropyl para-amino benzoic acid, Glyceryl PABA, Homosalate, methyl anthranilate, 2-phenyl-benzimidazole-5-sulphonic acid and others known in the art or any other suitable mixtures thereof.
  • the titanium dioxide may be selected from micronised, surface treated, hydrophilically or hydrophobically, powder form or predispersed. It is preferred that the average particle size of the titanium dioxide used according to the invention is less than 100 nm and, preferably, more than 50% of the particles (more preferably more than 75%) have an average particle size less than 100 nm.
  • the composition according to the invention can include cosmetically compatible carriers, preservatives, emulsifiers, thickeners, perfume and colour. Skin benefit materials such as moisturisers, emollients and anti-ageing compounds can also be used.
  • the vehicle which forms part of the cosmetic composition comprises one or more substances which are cosmetically acceptable in that they will not harm the skin.
  • the vehicles that can be used in the compositions according to the invention can include powder absorbents, binders and carriers, and liquids such as emollients, propellants, solvents, humectants and thickeners, for example polyols, glycerol, cetyl alcohol, esters, carbopol 934, ethoxylated castor oil, paraffin oils, lanolin and its derivatives, etc.
  • Silicone compounds such as silicone surfactants and/or silicone based emollients can be used optionally in the composition.
  • compositions according to the invention can be prepared for topical application to the skin in the form of conventional products such as lotions, powders, creams, ointments, sticks, aerosol and cleansing products .
  • Example 1 The compositions tested for anti-tanning and skin lightening are presented in Table 1.
  • Table 1 includes a composition comprising conventional actives but without titanium dioxide (Comparative Example 1) and a composition with micronised titanium dioxide (Example 1) -
  • test samples Fifteen subjects with non-hairy forearms and even skin color tone were selected.
  • the test samples (Comparative Example and Example 1) were applied on the forearm and marked out clearly.
  • the sample application was repeated on three consecutive days (Day 1, 2 &3) followed by sun exposure on the treated sites along with an untreated control site. Tanned spots are visually evaluated on the scale of 0 to 8 on the 5th and 10th day.
  • a ratio of Tan protection Index was calculated using a formula :
  • Tan Protection Index ⁇ [ (Mean tan score at the unprotected site ) - ( Mean tan score at the treated site) ] / (mean tan score at the unprotected site ) ⁇ .
  • Tan protection Index (TPI) of a formulation gives its efficacy compared to an untreated exposed site and a formulation that has a TPI of one is expected to give 100% protection against tan.
  • the data taken on day 5 and 10 are presented in Table 2.
  • the data presented shows that the anti-tanning effect obtained by the use of micronised titanium dioxide along with niacinamide is significantly superior even when the total level of the sunscreen in the composition was reduced. This shows that titanium dioxide acts synergistically in improving the antitanning effect.
  • Mean tan score is evaluated on the following scale NO DIFFERENCE 0
  • a panel of members with a skin colour range between subjective scores of 6.5 and 7.5 were selected for the study. They were divided into 2 groups and were given cream compositions according to the Comparative Example or Example 1. The volunteers applied the assigned cream (0.75 g) on one of their forearms leaving the other forearm untreated. This was done twice daily for 8 weeks. This was a blind study and the extent of reduction in skin colour was visually evaluated by an expert at the end of 8 weeks and data is presented in Table 3.
  • Example 2 The data shows that the extent of skin lightening produced by Example 2 is significantly superior as compared to Example 1 although the level of the skin lightening agent (niacinamide) is the same in both the samples. This shows that the titanium dioxide has a significant role in enhancing the skin lightening benefit of niacinamide.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions cosmétiques renfermant un agent d'éclaircissement de la peau (tel que du niacinamide) ou un précurseur de cet agent et des particules de dioxyde de titanium ayant une granulométrie inférieure à 100nm. Ces compositions sont utilisées pour éclaircir la couleur de la peau et inhiber ou empêcher le bronzage de la peau.
PCT/EP2001/002736 2000-03-23 2001-03-09 Compositions cosmetiques WO2001070190A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001256202A AU2001256202A1 (en) 2000-03-23 2001-03-09 Cosmetic compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN255MU2000 2000-03-23
IN255/MUM/00 2000-03-23

Publications (2)

Publication Number Publication Date
WO2001070190A2 true WO2001070190A2 (fr) 2001-09-27
WO2001070190A3 WO2001070190A3 (fr) 2002-05-10

Family

ID=11097230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/002736 WO2001070190A2 (fr) 2000-03-23 2001-03-09 Compositions cosmetiques

Country Status (3)

Country Link
AR (1) AR027981A1 (fr)
AU (1) AU2001256202A1 (fr)
WO (1) WO2001070190A2 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039502A1 (fr) * 2001-11-09 2003-05-15 Beiersdorf Ag Preparation cosmetique et/ou dermatologique contenant de l'acide dicarboxylique d'octadecene et des substances filtrant les u.v.
EP1506766A1 (fr) * 2003-08-11 2005-02-16 L'oreal Composition cosmétique comprenant des particules metalliques passivées, eventuellement enrobées
WO2005044214A1 (fr) * 2003-11-06 2005-05-19 Unilever Plc Composition cosmetique amelioree comportant de la vitamine b3, de la vitamine b6 et un acide organique
WO2007112853A1 (fr) * 2006-03-30 2007-10-11 Unilever Plc Agents, compositions et procedes d'eclaircissement de la peau
WO2009003996A1 (fr) * 2007-07-05 2009-01-08 Unilever Plc Composition cosmetique amelioree d'eclaircissement de la peau
FR2939669A1 (fr) * 2008-12-17 2010-06-18 Oreal Procede cosmetique pour controler le brunissement de la peau induit par les radiations uv ; compositions.
CN113633571A (zh) * 2020-05-11 2021-11-12 玫琳凯有限公司 亮白增强技术和亮白安瓿
US20230051886A1 (en) * 2006-01-19 2023-02-16 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007462A1 (fr) * 1992-09-30 1994-04-14 Unilever Plc Composition cosmetique contenant du retinol
WO1994009756A1 (fr) * 1992-11-05 1994-05-11 Unilever Plc Compositions cosmetiques contenant du retinol
WO1995011662A1 (fr) * 1993-10-26 1995-05-04 Unilever Plc Composition cosmetique comprenant une hydrocalchone ainsi que facultativement du retinol ou un derive de celui-ci
FR2723316A1 (fr) * 1994-08-04 1996-02-09 Thorel Jean Noel Compositions et preparations depigmentantes de la peau, a usages pharmaceutiques ou cosmetiques
FR2735688A1 (fr) * 1995-06-26 1996-12-27 Oreal Utilisation en association d'un alpha-hydroxyacide et d'un oxyde de titane pour le blanchiment de la peau

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007462A1 (fr) * 1992-09-30 1994-04-14 Unilever Plc Composition cosmetique contenant du retinol
WO1994009756A1 (fr) * 1992-11-05 1994-05-11 Unilever Plc Compositions cosmetiques contenant du retinol
WO1995011662A1 (fr) * 1993-10-26 1995-05-04 Unilever Plc Composition cosmetique comprenant une hydrocalchone ainsi que facultativement du retinol ou un derive de celui-ci
FR2723316A1 (fr) * 1994-08-04 1996-02-09 Thorel Jean Noel Compositions et preparations depigmentantes de la peau, a usages pharmaceutiques ou cosmetiques
FR2735688A1 (fr) * 1995-06-26 1996-12-27 Oreal Utilisation en association d'un alpha-hydroxyacide et d'un oxyde de titane pour le blanchiment de la peau

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039502A1 (fr) * 2001-11-09 2003-05-15 Beiersdorf Ag Preparation cosmetique et/ou dermatologique contenant de l'acide dicarboxylique d'octadecene et des substances filtrant les u.v.
EP1506766A1 (fr) * 2003-08-11 2005-02-16 L'oreal Composition cosmétique comprenant des particules metalliques passivées, eventuellement enrobées
FR2858767A1 (fr) * 2003-08-11 2005-02-18 Oreal Composition cosmetique comprenant des particules metalliques passivees, eventuellement enrobees
WO2005044214A1 (fr) * 2003-11-06 2005-05-19 Unilever Plc Composition cosmetique amelioree comportant de la vitamine b3, de la vitamine b6 et un acide organique
US7332152B2 (en) 2003-11-06 2008-02-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic composition
US20230051886A1 (en) * 2006-01-19 2023-02-16 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
CN101415399B (zh) * 2006-03-30 2011-11-16 荷兰联合利华有限公司 使皮肤色泽变淡的试剂和组合物
WO2007112853A1 (fr) * 2006-03-30 2007-10-11 Unilever Plc Agents, compositions et procedes d'eclaircissement de la peau
WO2009003996A1 (fr) * 2007-07-05 2009-01-08 Unilever Plc Composition cosmetique amelioree d'eclaircissement de la peau
WO2010078985A2 (fr) * 2008-12-17 2010-07-15 L'oreal Procédé cosmétique pour réguler le brunissement de la peau induit par un rayonnement uv et compositions
WO2010078985A3 (fr) * 2008-12-17 2011-03-10 L'oreal Procédé cosmétique pour réguler le brunissement de la peau induit par un rayonnement uv et compositions
CN102316844A (zh) * 2008-12-17 2012-01-11 莱雅公司 用于控制uv辐射诱导的皮肤晒黑的化妆方法和组合物
JP2012512215A (ja) * 2008-12-17 2012-05-31 ロレアル Ｕｖ照射によって誘発される皮膚の褐変化を制御するための化粧方法、組成物
CN102316844B (zh) * 2008-12-17 2015-06-17 莱雅公司 用于控制uv辐射诱导的皮肤晒黑的化妆方法和组合物
JP2016040334A (ja) * 2008-12-17 2016-03-24 ロレアル Ｕｖ照射によって誘発される皮膚の褐変化を制御するための化粧方法、組成物
JP2018048210A (ja) * 2008-12-17 2018-03-29 ロレアル Ｕｖ照射によって誘発される皮膚の褐変化を制御するための化粧方法、組成物
FR2939669A1 (fr) * 2008-12-17 2010-06-18 Oreal Procede cosmetique pour controler le brunissement de la peau induit par les radiations uv ; compositions.
CN113633571A (zh) * 2020-05-11 2021-11-12 玫琳凯有限公司 亮白增强技术和亮白安瓿

Also Published As

Publication number Publication date
WO2001070190A3 (fr) 2002-05-10
AU2001256202A1 (en) 2001-10-03
AR027981A1 (es) 2003-04-23

Similar Documents

Publication Publication Date Title
US5152983A (en) Sunscreen compositions comprising pongomol
EP0514067B1 (fr) Composition cosmétique
US5196187A (en) Cosmetic composition
US5188831A (en) Sunscreens containing both water and oil dispersible titanium dioxide particles
AU680844B2 (en) Retinol containing cosmetic composition
EP2247949B1 (fr) Procédé de sélection d'antioxydants pour une utilisation dans des compositions appliquées topiquement
US5292529A (en) Preserved sunscreen composition
AU699467B2 (en) Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof
EP0396422B1 (fr) Composition pour la peau
GB2275190A (en) Sunscreen composition comprising titanium dioxide and octyl methoxycinnamate
KR100667124B1 (ko) 각질층 기능 향상을 위한 콜레스테롤 술페이트 조성물
WO2001070190A2 (fr) Compositions cosmetiques
JPH08507542A (ja) 皮膚の人工的日焼け用の化粧用組成物
GB2230186A (en) Skin composition
FR2803200A1 (fr) Composition cosmetique photoprotectrice contenant un extrait d'algue marine
WO2009003996A1 (fr) Composition cosmetique amelioree d'eclaircissement de la peau
EP2299967A2 (fr) Methode d'eclaircissement de la peau
EP1338269B1 (fr) Utilisation de créatinine et/ou des dérivés de créatinine pour éclaircir la peau et pour soulager les désordres de pigmentation
US20060228309A1 (en) Skin lightening composition comprising an extract of plants from the families of symplocos or rubia
WO1998038966A1 (fr) Compositions d'ecrans solaires a base de fragments d'arn endommages
AU730661B2 (en) Sunscreen composition
Brown et al. Sun damage and sunscreen preparations
ZA200509652B (en) Skin lightening composition comprising an extract of plants from the families of symplocos or rubia
MXPA00007158A (en) Skin lightening composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP